Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender

Overview

Journal Am J Prev Med

Specialty Public Health

Date 2020 Sep 28

PMID 32981768

Citations 17

Authors

Morgan M Philbin

Emily R Greene

Silvia S Martins

Natalie J LaBossier

Pia M Mauro

Affiliations

Soon will be listed here.

Abstract

Introduction: Major knowledge gaps regarding medical and nonmedical prescription stimulant use and illegal stimulant use (i.e., cocaine/crack/methamphetamine) by sexual identity and gender have implications for individuals' health and well-being. This study improves stimulant use measurement by differentiating the type of stimulant use and focusing on lesbian, gay, and bisexual subpopulations.

Methods: Data were pooled for adults in the 2015-2017 National Survey on Drug Use and Health (n=126,463; analyzed in 2019). Gender-stratified logistic regression models examined associations between sexual identity and past-year illegal stimulant use. Gender-stratified multinomial logistic regression models estimated odds of (1) medical use only versus no past-year prescription stimulant use, (2) any nonmedical stimulant use versus no past-year use, and (3) any nonmedical stimulant use versus medical use only.

Results: Illegal stimulant use varied by sexual identity (men: gay, 9.2%; bisexual, 7.5%; heterosexual, 3.2%; women: gay/lesbian, 3.2%; bisexual, 7.8%; heterosexual, 1.5%), as did nonmedical prescription stimulant use. Relative to same-gender heterosexuals, gay (AOR=2.61, 95% CI=2.00, 3.40) and bisexual (AOR=1.70, 95% CI=1.24, 2.33) men had higher odds of past-year illegal stimulant use, as did gay/lesbian (AOR=1.63, 95% CI=1.16, 2.28) and bisexual (AOR=2.70, 95% CI=2.23, 3.26) women. Sexual minorities reported higher odds of nonmedical prescription stimulant use than heterosexuals. Any nonmedical prescription opioid use was reported by 26.4% of people who reported nonmedical stimulant use and 27.0% of people who reported illegal stimulant use.

Conclusions: Lesbian, gay, and bisexual individuals had a higher prevalence of stimulant use than their heterosexual counterparts. This has important implications for health disparities, especially given the high levels of polysubstance use. Taking a multilevel approach is crucial to reduce stimulant-related harms for lesbian, gay, and bisexual individuals.

Citing Articles

Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial.

Davis-Ewart L, Atkins L, Ghanooni D, Diaz J, Chuku C, Balise R BMC Public Health. 2024; 24(1):2350.

PMID: 39210314 PMC: 11360769. DOI: 10.1186/s12889-024-19745-7.

Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants.

Diaz J, Ghanooni D, Atkins L, Sam S, Kantor R, Miller-Perusse M AIDS Behav. 2024; 28(11):3809-3818.

PMID: 39126558 DOI: 10.1007/s10461-024-04453-5.

Substance Use Over Time Among Sexual and Gender Minority People: Differences at the Intersection of Sex and Gender.

Flentje A, Sunder G, Ceja A, Lisha N, Neilands T, Aouizerat B LGBT Health. 2024; 11(4):269-281.

PMID: 38206680 PMC: 11522414. DOI: 10.1089/lgbt.2023.0055.

Psychostimulant Misuse Among American Indian, Alaskan Native, or Native Hawaiian College Students in the U.S. From 2015 to 2019.

Qeadan F, Ross S, Barbeau W, Madden E, Venner K, English K Subst Abuse. 2023; 17:11782218231209667.

PMID: 38025909 PMC: 10655647. DOI: 10.1177/11782218231209667.

Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.

McHugh R, Korte F, Bichon J, Weiss R Am J Addict. 2023; 33(3):283-289.

PMID: 37924248 PMC: 11032236. DOI: 10.1111/ajad.13501.

References

Sweeney C, Sembower M, Ertischek M, Shiffman S, Schnoll S . Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse. J Addict Dis. 2013; 32(1):1-10. PMC: 3630453. DOI: 10.1080/10550887.2012.759858. View

Hatzenbuehler M, Jun H, Corliss H, Austin S . Structural stigma and sexual orientation disparities in adolescent drug use. Addict Behav. 2015; 46:14-8. PMC: 4395540. DOI: 10.1016/j.addbeh.2015.02.017. View

Kerr D, Ding K, Chaya J . Substance use of lesbian, gay, bisexual and heterosexual college students. Am J Health Behav. 2014; 38(6):951-62. DOI: 10.5993/AJHB.38.6.17. View

Newcomb M, Ryan D, Greene G, Garofalo R, Mustanski B . Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men. Drug Alcohol Depend. 2014; 141:65-71. PMC: 4158827. DOI: 10.1016/j.drugalcdep.2014.05.005. View

Plankey M, Ostrow D, Stall R, Cox C, Li X, Peck J . The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007; 45(1):85-92. PMC: 3486782. DOI: 10.1097/QAI.0b013e3180417c99. View

Safer D . Recent Trends in Stimulant Usage. J Atten Disord. 2015; 20(6):471-7. DOI: 10.1177/1087054715605915. View

Benotsch E, Martin A, Koester S, Cejka A, Luckman D . Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sex Transm Dis. 2010; 38(2):105-10. DOI: 10.1097/OLQ.0b013e3181f0bc4b. View

Zaza S, Kann L, Barrios L . Lesbian, Gay, and Bisexual Adolescents: Population Estimate and Prevalence of Health Behaviors. JAMA. 2016; 316(22):2355-2356. PMC: 5541373. DOI: 10.1001/jama.2016.11683. View

LaRue L, Twillman R, Dawson E, Whitley P, Frasco M, Huskey A . Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine. JAMA Netw Open. 2019; 2(4):e192851. PMC: 6487565. DOI: 10.1001/jamanetworkopen.2019.2851. View

10.

Molina B, Hinshaw S, Eugene Arnold L, Swanson J, Pelham W, Hechtman L . Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013; 52(3):250-63. PMC: 3589108. DOI: 10.1016/j.jaac.2012.12.014. View

11.

Friedman M, Dodge B, Schick V, Herbenick D, Hubach R, Bowling J . FROM BIAS TO BISEXUAL HEALTH DISPARITIES: ATTITUDES TOWARD BISEXUAL MEN AND WOMEN IN THE UNITED STATES. LGBT Health. 2015; 1(4):309-318. PMC: 4283842. DOI: 10.1089/lgbt.2014.0005. View

12.

Cochran S, Ackerman D, Mays V, Ross M . Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addiction. 2004; 99(8):989-98. PMC: 4190042. DOI: 10.1111/j.1360-0443.2004.00759.x. View

13.

Philbin M, Mauro P . Measuring polysubstance use over the life course: implications for multilevel interventions. Lancet Psychiatry. 2019; 6(10):797-798. PMC: 7213041. DOI: 10.1016/S2215-0366(19)30328-1. View

14.

Philbin M, Mauro P, Greene E, Martins S . State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter. Drug Alcohol Depend. 2019; 204:107506. PMC: 6878202. DOI: 10.1016/j.drugalcdep.2019.06.009. View

15.

Nolan M, Shamasunder S, Colon-Berezin C, Kunins H, Paone D . Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention. J Urban Health. 2019; 96(1):49-54. PMC: 6391300. DOI: 10.1007/s11524-018-00343-z. View

16.

Daniulaityte R, Juhascik M, Strayer K, Sizemore I, Zatreh M, Nahhas R . Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017. Drug Alcohol Depend. 2019; 198:116-120. PMC: 9419823. DOI: 10.1016/j.drugalcdep.2019.01.045. View

17.

Durell T, Kroutil L, Crits-Christoph P, Barchha N, Van Brunt D . Prevalence of nonmedical methamphetamine use in the United States. Subst Abuse Treat Prev Policy. 2008; 3:19. PMC: 2515829. DOI: 10.1186/1747-597X-3-19. View

18.

Seth P, Scholl L, Rudd R, Bacon S . Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018; 67(12):349-358. PMC: 5877356. DOI: 10.15585/mmwr.mm6712a1. View

19.

Dowell D, Zhang K, Noonan R, Hockenberry J . Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates. Health Aff (Millwood). 2016; 35(10):1876-1883. PMC: 6583870. DOI: 10.1377/hlthaff.2016.0448. View

20.

Arria A, Dupont R . Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do. J Addict Dis. 2010; 29(4):417-26. PMC: 2951617. DOI: 10.1080/10550887.2010.509273. View